Results 211 to 220 of about 295,552 (260)

Robust 3D Pose estimation and Parkinson's Disease classification via Dual-Stage Adaptive Temporal Perception and graph topology modeling network. [PDF]

PLoS One
Zuo M, Li J, Chang M, Zhang Q, Fan S.
europepmc   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

WHODAS 2.0 to Assess Disability in the Rehabilitation of Individuals With Chronic Respiratory Conditions: Responsiveness and Interpretability. [PDF]

Physiother Res Int
Lopes CCC, Lima VG, Formiga MF, Mesquita R.   +3 more
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Hybrid deep learning framework for accurate classification of high dimensional genomic data. [PDF]

Sci Rep
Swain MK, Kamila NK, Jena L, Chithaluru P, Albeshri MY, Alsekait DM.   +5 more
europepmc   +1 more source

Privileged structure-based molecular fingerprints for organic electronic materials: towards intuitive machine learning interpretation. [PDF]

J Cheminform
Yang TW, Jo SH, Suh MC.
europepmc   +1 more source

Machine learning-based prediction model for chronic post-surgical pelvic pain syndrome: a comprehensive analysis using SHAP interpretability. [PDF]

Eur J Med Res
Xi J, Wang Z, Xu Z, Shi Y, Zhang Y.
europepmc   +1 more source

Explainable artificial intelligence (XAI) in medical imaging: a systematic review of techniques, applications, and challenges. [PDF]

BMC Med Imaging
Ahmed F, Naz NS, Khan S, Rehman AU, Ismael WM, Khan MA.   +5 more
europepmc   +1 more source